v3.24.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2021   223,724        
Beginning balance at Jan. 31, 2021 $ 871,874 $ 112 $ 1,598,259 $ (730,116) $ 2,319 $ 1,300
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   2,598        
Issuance of common stock upon exercise of options 15,899 $ 1 15,898      
Issuance of common stock under RSU and PSU release (in shares)   3,408        
Issuance of common stock under RSU and PSU release 0 $ 2 (2)      
Issuance of common stock under employee stock purchase plan (in shares)   904        
Issuance of common stock under employee stock purchase plan 50,277   50,277      
Issuance of common stock for restricted stock awards (in shares)   57        
Vesting of early exercised options 3,165   3,165      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   15        
Issuance of common stock for founders holdbacks related to acquisitions 3,528   3,528      
Stock-based compensation expense 305,792   305,792      
Capitalized stock-based compensation 10,879   10,879      
Fair value of replacement equity awards attributable to pre-acquisition service 4,011   4,011      
Net income (loss) (232,378)     (234,802)   2,424
Non-controlling interest 8,155         8,155
Other comprehensive income (loss) (3,559)       (3,559)  
Ending balance (in shares) at Jan. 31, 2022   230,706        
Ending balance at Jan. 31, 2022 1,037,643 $ 115 1,991,807 (964,918) (1,240) 11,879
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   1,032        
Issuance of common stock upon exercise of options 8,655 $ 3 8,652      
Issuance of common stock under RSU and PSU release (in shares)   3,444        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   517        
Issuance of common stock under employee stock purchase plan 59,419   59,419      
Issuance of common stock for restricted stock awards (in shares)   6        
Vesting of early exercised options 2,204   2,204      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   72        
Issuance of common stock for founders holdbacks related to acquisitions 10,645   10,645      
Stock-based compensation expense 519,735   519,735      
Capitalized stock-based compensation 20,193   20,193      
Fair value of replacement equity awards attributable to pre-acquisition service 50   50      
Net income (loss) (182,285)     (183,245)   960
Non-controlling interest 10,954         10,954
Other comprehensive income (loss) 221       221  
Ending balance (in shares) at Jan. 31, 2023   235,777        
Ending balance at Jan. 31, 2023 $ 1,487,434 $ 118 2,612,705 (1,148,163) (1,019) 23,793
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 1,146 1,146        
Issuance of common stock upon exercise of options $ 8,695 $ 2 8,693      
Issuance of common stock under RSU and PSU release (in shares)   4,041        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   747        
Issuance of common stock under employee stock purchase plan 76,375 $ 1 76,374      
Issuance of common stock for restricted stock awards (in shares)   125        
Vesting of early exercised options 0          
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   27        
Issuance of common stock for founders holdbacks related to acquisitions 4,314   4,314      
Issuance of common stock for payment of board of director fees (in shares)   2        
Issuance of common stock for payment of board of director fees 344   344      
Stock-based compensation expense 626,861   626,861      
Capitalized stock-based compensation 34,385   34,385      
Fair value of replacement equity awards attributable to pre-acquisition service 652   652      
Net income (loss) 90,585     89,327   1,258
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) (644)       (644)  
Ending balance (in shares) at Jan. 31, 2024   241,865        
Ending balance at Jan. 31, 2024 $ 2,337,089 $ 121 $ 3,364,328 $ (1,058,836) $ (1,663) $ 33,139